PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 26, 2005 Subscribe to this News Feed    
 

NuLiv Announces New Way To Treat High Cholesterol, Blood Pressure

NuLiv Lifestyle has introduced a break-through complete cardiovascular supplement that improves cholesterol and high blood pressure.

(PRWEB) June 26, 2005 -- After 5 months of collaborative research between NuLivs R&D staff and Taiwan Defense Medical University, NuLiv has formally introduced CardioXine for overall cardiovascular support.

Dr. Thomas Yang, clinically trained at University of Texas Southwestern Medical Center and head of Research & Development at NuLiv Lifestyle. We poured over countless research pages and manuals from old Chinese herbal guides and realize that while a few formulas dated back to hundreds of years, they were years ahead of their time"

After applying established scientific protocols and reviewing currently accepted minerals and vitamins for cardiovascular health, Dr. Yang and research partners at Taiwan Defense Medical University developed the CardioXine formula. The active ingredients in CardioXine include Vitamin B6, B12, Folic Acid , Rosa Roxburghii, Gynostemma Pentaphyllum and Cordyceps Sinensis.

About NuLiv Lifestyle
Founded in 1997. Global nutraceutical company with research partnerships in the United Kingdom, Taiwan and China. Currently markets in North America six proprietary natural supplements for anti-aging, bone support, cardiovascular health, seasonal allergies, stress and weight management.

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Richard Wang
NULIV LIFESTYLE
6269057154
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.